Scheffler, Armin
Schenk, Hannah
Wurthmann, Sebastian
Nsaka, Michael
Kleinschnitz, Christoph
Glas, Martin
Holle, Dagny
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 19 July 2021
Accepted: 6 September 2021
First Online: 20 September 2021
Declarations
:
: The analysis was approved by the independent ethics committee of the University Hospital Essen (19-9004-BO) and all patients gave written consent to general analysis of their personal and clinical data.
: Not applicable.
: Martin Glas received honoraria from Novartis, UCB, Teva, Bayer, Novocure, Medac, Merck, Kyowa Kirin, has a consulting or advisory role to declare for Roche, Novartis, AbbVie, Novocure, and Daiichi Synkyo, and received travel fees from Novocure and Medac.Dagny Holle has received scientific support and/or honoraria from Biogen, Novartis, Lilly, Sanofi-Aventis, Teva, Allergan, Hormosan.Christoph Kleinschnitz has received honoraria, a consulting or advisory role to declare for Alexion, Almirall, Amgen, Amicus, Bayer, Biogen, Biotronik, Boehringer Ingelheim, Bristol Myers-Squibb, Celgene, CSL Behring, Daiichi Sankyo, Desitin, Eisai, Ever Pharma, GE Healthcare, MedDay Pharmaceuticals, Merck Serono, Mylan, Novartis, Pfizer, Roche, Sanofi-Genzyme, Siemens, Stago, Teva.Michael Nsaka received travel fees from Licher MT.Armin Scheffler received travel fees from Teva, honoraria for participation on an advisory board of Novartis.Sebastian Wurthmann reports personal fees from Allergan, personal fees from Teva, personal fees from Novartis, outside the submitted work.Hannah Schenk declares that there is no conflict of interest.